| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| acetylcholinesterase | 2 | 0 | 0 | 2 |
| thioredoxin reductase | 2 | 0 | 0 | 2 |
| RAR-related orphan receptor gamma | 4 | 0 | 0 | 4 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| GLI family zinc finger 3 | 3 | 0 | 0 | 3 |
| AR protein | 2 | 0 | 0 | 2 |
| signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
| thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
| regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
| EWS/FLI fusion protein | 1 | 0 | 0 | 1 |
| estrogen nuclear receptor alpha | 6 | 0 | 0 | 6 |
| putative alpha-glucosidase | 1 | 0 | 0 | 1 |
| euchromatic histone-lysine N-methyltransferase 2 | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform 2 | 1 | 0 | 0 | 1 |
| heat shock protein beta-1 | 1 | 0 | 0 | 1 |
| peripheral myelin protein 22 | 3 | 0 | 0 | 3 |
| histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
| lamin isoform A-delta10 | 3 | 0 | 0 | 3 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 1 | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Matrix protein 2 | 0 | 1 | 1 | 2 |
| Matrix protein 2 | 0 | 1 | 2 | 3 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 2 | 0 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 2 | 0 | 0 | 2 |
| Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
| thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
| glucocorticoid receptor [Homo sapiens] | 2 | 0 | 0 | 2 |
| farnesoid X nuclear receptor | 1 | 0 | 0 | 1 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 2 | 0 | 0 | 2 |
| chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
| ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
| DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
| geminin | 3 | 0 | 0 | 3 |
| Luciferase | 2 | 0 | 0 | 2 |
| interleukin 8 | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
| nuclear receptor subfamily 1, group I, member 3 | 1 | 0 | 0 | 1 |
| progesterone receptor | 2 | 0 | 0 | 2 |
| retinoic acid nuclear receptor alpha variant 1 | 2 | 0 | 0 | 2 |
| retinoid X nuclear receptor alpha | 2 | 0 | 0 | 2 |
| estrogen-related nuclear receptor alpha | 3 | 0 | 0 | 3 |
| peroxisome proliferator-activated receptor delta | 1 | 0 | 0 | 1 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 2 | 0 | 0 | 2 |
| Histone H2A.x | 1 | 0 | 0 | 1 |
| Voltage-dependent calcium channel gamma-2 subunit | 2 | 0 | 0 | 2 |
| Cellular tumor antigen p53 | 2 | 0 | 0 | 2 |
| Glutamate receptor 2 | 2 | 0 | 0 | 2 |
| Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
| Chain A, Dutpase | 0 | 0 | 1 | 1 |
| Chain A, Dutpase | 0 | 0 | 1 | 1 |
| Chain B, Dutpase | 0 | 0 | 1 | 1 |
| Chain A, Dutpase | 0 | 0 | 1 | 1 |
| Chain B, Dutpase | 0 | 0 | 1 | 1 |
| Thymidine kinase, cytosolic | 0 | 0 | 0 | 1 |
| Thymidine phosphorylase | 0 | 0 | 0 | 1 |
| pregnane X nuclear receptor | 2 | 0 | 0 | 2 |
| peroxisome proliferator activated receptor gamma | 2 | 0 | 0 | 2 |
| aryl hydrocarbon receptor | 1 | 0 | 0 | 1 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 1 | 0 | 0 | 1 |
| activating transcription factor 6 | 1 | 0 | 0 | 1 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 2 | 0 | 0 | 2 |
| glp-1 receptor, partial | 1 | 0 | 0 | 1 |
| GALC protein | 1 | 0 | 0 | 1 |
| TDP1 protein | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
| IDH1 | 1 | 0 | 0 | 1 |
| thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
| beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
| Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
| Vpr | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 1 | 0 | 0 | 1 |
| G | 1 | 0 | 0 | 1 |
| Interferon beta | 1 | 0 | 0 | 1 |
| HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
| 30S ribosomal protein S6 | 0 | 1 | 0 | 2 |
| 30S ribosomal protein S7 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L15 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L10 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L11 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L7/L12 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L19 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L1 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L20 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L27 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L28 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L29 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L31 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L31 type B | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L32 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L33 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L34 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L35 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L36 | 0 | 1 | 0 | 2 |
| 30S ribosomal protein S10 | 0 | 1 | 0 | 2 |
| 30S ribosomal protein S11 | 0 | 1 | 0 | 2 |
| 30S ribosomal protein S12 | 0 | 1 | 0 | 2 |
| 30S ribosomal protein S13 | 0 | 1 | 0 | 2 |
| 30S ribosomal protein S16 | 0 | 1 | 0 | 2 |
| 30S ribosomal protein S18 | 0 | 1 | 0 | 2 |
| 30S ribosomal protein S19 | 0 | 1 | 0 | 2 |
| 30S ribosomal protein S20 | 0 | 1 | 0 | 2 |
| 30S ribosomal protein S2 | 0 | 1 | 0 | 2 |
| 30S ribosomal protein S3 | 0 | 1 | 0 | 2 |
| 30S ribosomal protein S4 | 0 | 1 | 0 | 2 |
| 30S ribosomal protein S5 | 0 | 1 | 0 | 2 |
| 30S ribosomal protein S8 | 0 | 1 | 0 | 2 |
| 30S ribosomal protein S9 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L13 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L14 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L16 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L23 | 0 | 1 | 0 | 2 |
| 30S ribosomal protein S15 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L17 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L21 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L30 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L6 | 0 | 1 | 0 | 2 |
| 30S ribosomal protein S14 | 0 | 1 | 0 | 2 |
| 30S ribosomal protein S17 | 0 | 1 | 0 | 2 |
| 30S ribosomal protein S1 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L18 | 0 | 1 | 0 | 2 |
| Aminopeptidase N | 0 | 1 | 0 | 1 |
| Aminopeptidase N | 0 | 1 | 0 | 1 |
| Puromycin-sensitive aminopeptidase | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L2 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L3 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L24 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L4 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L22 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L5 | 0 | 1 | 0 | 2 |
| 30S ribosomal protein S21 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L25 | 0 | 1 | 0 | 2 |
| 50S ribosomal protein L36 2 | 0 | 1 | 0 | 2 |
| Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
| Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
| mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
| Chain A, MALTOPORIN | 0 | 0 | 1 | 1 |
| Chain B, MALTOPORIN | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 1 | 2 |
| Carbonic anhydrase 9 | 0 | 1 | 1 | 2 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |